Stacy McCarron
Nurse Practitioner · Grand Rapids, MINPI 1649213133
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,916 of the $3,247 with a category attached, or 89.8%. It is spread thinly across 26 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,681 and has fallen 79.0% since, to $353 in 2025. Among nurse practitioner clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $33.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$450
- AstraZeneca$412
- Incyte Corporation$373
- Johnson & Johnson$362
- GSK$291
- Pharmacyclics LLC, An Abbvie Company$216
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,91690%
- Education$33110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 4 | $450 |
| AstraZeneca | 6 | $412 |
| Incyte Corporation | 4 | $373 |
| Johnson & Johnson | 6 | $362 |
| GSK | 5 | $291 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $216 |
| Seagen Inc. | 9 | $147 |
| Array Biopharma Inc | 7 | $139 |
| Genentech USA, Inc. | 7 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $127 |
| Bristol Myers Squibb | 9 | $117 |
| Novartis | 3 | $60 |
| Kyowa Kirin, Inc. | 3 | $52 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
| Pfizer | 3 | $40 |
| Karyopharm Therapeutics Inc. | 2 | $38 |
| Sanofi | 2 | $38 |
| Gilead | 2 | $37 |
| ADC Therapeutics America, Inc. | 2 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| Myovant Sciences Inc. | 1 | $17 |
| Bayer | 1 | $13 |
| Agios Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,247 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Grand Rapids
- Debra DegraffGrand Rapids$80K
- Aaron EmmonsGrand Rapids$29K
- Natasha PeoplesGrand Rapids$12K
- Davida KrugerDetroit$739K
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.